U.S. Markets closed

Abattis Bioceuticals Corp. (ATTBF)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.151+0.01 (+3.78%)
At close: 3:56PM EDT
People also watch
EDXCNDEVCNABMCIGMNTR
  • this is a hold
  • Is this the bottom? Back down to before the run into the .20's.
  • Anyone still buying at 0.21?
  • this is always good for this company and i believe its only gonna get more stringent
  • News of a deal with a large LP could easily send this back into the .30's. That's what I'm waiting for.
  • This is sucking gutter water!
    Imagerhetthammersmithhorror
  • not known yet to the masses
  • Finally an up day close.
  • Health Canada's new guidelines announced on Friday, May 5, which require mandatory testing for unauthorized pesticides by all Licensed Producers, 
  • Northern Vine is GOING places! The new marketing director is starting an educational campaign SOON. http://abattis.club/news/abattis-northern-vine-labs-expands-sales-team-pr

  • I have an avg price per share of $0.24. Anybody expect it to surpass that?
  • Time to move up! Great company, way undervalued right now!
  • I'm ready for a big push up....I see a bottom
  • when all the bashing and uncertainty ends and its legalized officially, this company is a no brainer and it will take off
  • Seriously....this hasn't been a good month....hopefully it will keep rising!
  • Congratulations ATTBF holders! Patience pays. Northern Vine is officially open. Abattis is now setup to transition from a development company to a revenue/profit producing company.
    Abattis Announces the Official Launch of Northern Vine Laboratory (PR) - Abattis Club
    Vancouver, British Columbia / Newsfile Corp / May 3, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that its subsidiary, Northern Vine Canada Inc. (“Northern Vine“), has officially launch
    abattis.club
  • this baby wont stay here forever.
  • I got in on this at C$0.32, do you guys think this will go up again soon?
  • Bought in at US$ .237. This feels like a slow death.